Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroma Security Regulatory News (CSSG)

Share Price Information for Croma Security (CSSG)

Share Price is delayed by 15 minutes
Get Live Data
67.50    0.00 (0.00%)
Bid:
65.00
Ask:
70.00
Spread: 5.00 (7.692%)
Market Cap: £9.29m
CSSG Live PriceLast checked at - London Stock Exchange

Intraday Croma Security Share Chart

Issue of Equity

16 Nov 2009 18:18

RNS Number : 5997C
Croma Group PLC
16 November 2009
 



Croma Group PLC

Issue of equity and directors' dealings 

The Board of Croma Group PLC ("Croma" or the "Company") announces that, on 16 November 2009, it issued and allotted 6,500,000 new ordinary shares of 0.1 pence each ("New Ordinary Shares") (representing approximately 3.66 per cent. of the current issued share capital of the Company) at a price of 2.0 pence per share (the "Subscription Price"), to directors raising £130,000 (before expenses) pursuant to a subscription. The net subscription proceeds will be used for the repayment of debt. 

The New Ordinary Shares are being subscribed for under existing authorities to issue and allot shares. 

Application has been made to the London Stock Exchange for the 6,500,000 New Ordinary Shares to be admitted to trading on AIM and it is expected that dealings will commence on or around 20 November 2009. 

Directors' dealings 

Pursuant to the subscription, Sebastian Morley, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price. Following this transaction, Sebastian Morley's beneficial interest in the Company is 21,028,634 ordinary shares, representing approximately 11.44 per cent. of the enlarged issued share capital of the Company. 

Gerald McGill, a director of the Company, has subscribed for 500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Gerald McGill's beneficial interest in the Company is 1,250,000 ordinary shares, representing approximately 0.68 per cent. of the enlarged issued share capital of the Company. 

James Sullivan, a director of the Company, has subscribed for 1,000,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, James Sullivan's beneficial interest in the Company is 1,000,000 ordinary shares, representing approximately 0.54 per cent. of the enlarged issued share capital of the Company. 

Furthermore, Nicholas Hewson, a director of the Company, has subscribed for 2,500,000 New Ordinary Shares at the Subscription Price pursuant to the subscription. Following this transaction, Nicholas Hewson's beneficial interest in the Company is 6,354,342 ordinary shares, representing approximately 3.46 per cent. of the enlarged issued share capital of the Company. 

Total Voting Rights

In accordance with FSA's Disclosure and Transparency Rules, the Company advises that its increased issued share capital comprises 183,883,964 ordinary shares of 0.1 pence each. The voting rights of all of these shares are identical with each share carrying the right to one vote. The Company holds no ordinary shares in Treasury. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Croma Group Plc under the Disclosure and Transparency Rules.

For further information contact:

Croma Group PLC:

Sebastian Morley, CEO

Tel: 07768 006909

Brewin Dolphin:

Sandy Fraser, Managing Director - Corporate Finance (NOMAD)

Tel: 0845 213 2072

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEBFBPTMMBBBPL
Date   Source Headline
16th Mar 20267:00 amRNSAcquisition
16th Mar 20267:00 amRNSAcquisition
26th Feb 20267:00 amRNSHalf-year Financial Report
23rd Feb 20264:58 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSNotice of Results
15th Jan 20268:32 amRNSDirector Dealing
5th Jan 20267:00 amRNSAcquisition
1st Dec 202511:30 amRNSResult of AGM
25th Nov 20257:00 amRNSNotice of AGM
3rd Nov 20257:00 amRNSFinal Results
30th Oct 20257:00 amRNSNotice of Results and Investor Presentation
23rd Oct 20257:00 amRNSDirectorate Change
5th Sep 20251:59 pmRNSBoard Change
2nd Sep 20253:29 pmRNSBoard Change
16th Jul 202511:19 amRNSHolding(s) in Company
9th Jul 20257:00 amRNSTrading Statement
8th May 20253:55 pmRNSDirector/PCA Dealings
25th Apr 20256:10 pmRNSDirector/PDMR Shareholding
1st Apr 20257:00 amRNSAcquisition
6th Mar 20257:00 amRNSGrant of Options
24th Feb 20257:00 amRNSHalf-year Report
19th Feb 20257:00 amRNSNotice of Results and Investor Presentations
3rd Feb 20257:00 amRNSAcquisition
20th Jan 20257:00 amRNSTrading Statement
4th Dec 20249:26 amRNSResult of AGM
4th Dec 20247:00 amRNSAGM Statement
28th Nov 20247:00 amRNSNotice of AGM
5th Nov 202411:10 amRNSDirector Dealing
5th Nov 20247:00 amRNSNotice of Investor Presentation
4th Nov 20247:00 amRNSFinal Results
29th Oct 20242:38 pmRNSDirector/PCA Dealings
14th Aug 20247:00 amRNSHolding(s) in Company
22nd Jul 20247:00 amRNSTrading Statement
15th Jul 20247:00 amRNSChange of Adviser
8th Jul 20247:00 amRNSReceipt of Deferred Consideration
3rd Apr 20247:00 amRNSNHS Contract Win
21st Feb 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNSTrading Statement
8th Jan 20247:00 amRNSAcquisition
1st Dec 202310:24 amRNSResult of AGM
16th Nov 20237:00 amRNSNotice of AGM
13th Nov 202312:54 pmRNSDirector Dealing
13th Nov 20237:00 amRNSGrant of Options
8th Nov 20237:00 amRNSNotice of Investor Presentation
7th Nov 20237:00 amRNSFinal Results
26th Oct 20232:42 pmRNSTransaction in own shares and total voting rights
26th Oct 20237:00 amRNSTransaction in own shares and total voting rights
8th Aug 202310:17 amRNSHolding(s) in Company
7th Aug 202311:10 amRNSHolding(s) in Company
4th Aug 20237:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.